Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

HK1 – Charcot-Marie-Tooth Disease Type 4G

Hexokinase 1 (HK1) is associated with autosomal recessive Charcot-Marie-Tooth disease type 4G (CMT4G), a demyelinating sensorimotor neuropathy characterized by progressive distal limb weakness and sensory loss (HK1; Charcot-Marie-Tooth Disease Type 4G).

CMT4G was first identified in the Balkan Roma population as a childhood-onset myelinopathy linked to two homozygous founder variants in the 5′ untranslated region (UTR) of HK1 (g.9712G>C and g.11027G>A) that segregate with disease in multiple gypsy families (PMID:19536174).

Affected individuals typically present in the first decade with distal lower limb weakness, followed by upper limb involvement and prominent distal sensory impairment, reflecting a chronic demyelinating sensorimotor polyneuropathy phenotype.

Whole-exome sequencing in an Iranian CMT4G patient revealed a homozygous nonsense variant c.19C>T (p.Arg7Ter), marking the first report of this coding change outside European Roma and expanding the mutational spectrum of HK1-related CMT (PMID:38301092).

The same p.Arg7Ter variant was subsequently identified in an unrelated Pakistani patient, suggesting a possible prevalence of this allele in Middle Eastern populations (PMID:38301092).

Functional assays demonstrate that CMT4G-associated HK1 5′UTR mutations disrupt HK1 binding to the voltage-dependent anion channel 1 (VDAC1), leading to impaired mitochondrial calcium buffering in patient cells, whereas expression of wild-type HK1 or an N-terminal peptide restores VDAC1 interaction and calcium handling in vitro (PMID:38673950).

Taken together, genetic and experimental data robustly support a loss-of-normal HK1–VDAC1 interaction as the pathogenic mechanism in CMT4G. Key take-home: identification of HK1 5′UTR or truncating variants enables molecular diagnosis and informs therapeutic strategies targeting mitochondrial calcium homeostasis.

References

  • European Journal of Human Genetics • 2009 • A mutation in an alternative untranslated exon of hexokinase 1 associated with hereditary motor and sensory neuropathy -- Russe (HMSNR). PMID:19536174
  • Archives of Iranian Medicine • 2023 • Expanding the Molecular Spectrum of HK1-Related Charcot-Marie-Tooth Disease, Type 4G; the First Report in Iran. PMID:38301092
  • International Journal of Molecular Sciences • 2024 • The Hexokinase 1 5′-UTR Mutation in Charcot-Marie-Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium Buffering. PMID:38673950

Evidence Based Scoring (AI generated)

Gene–Disease Association

Strong

Autosomal recessive CMT4G in multiple families across Roma, Iranian, and Pakistani populations with recurrent founder and truncating HK1 variants

Genetic Evidence

Strong

Recurrent homozygous 5′UTR variants in >25 probands and truncating c.19C>T (p.Arg7Ter) in multiple unrelated cases

Functional Evidence

Moderate

Disruption of HK1–VDAC1 binding and mitochondrial calcium buffering in patient cells; rescue by wild-type HK1 peptide in vitro